"We as a company care deeply—about our patients, our employees, the environment and our communities. We recognize that we have an opportunity to change medicine for all, and we will continue to make corporate responsibility a critical part of who we are and what we do."
Medicines for patients
Our commitment is to provide effective and affordable mRNA medicines to all populations. Through our platform, we are playing an important role in supporting a rapid response to the global pandemic.
Mill doses of the Moderna COVID-19 vaccine delivered by the end of 2021
of all doses of our COVID-19 Vaccine delivered in 2021 went to low- and middle-income countries
From our state-of-the-art mRNA facility in Africa to accelerating the creation of new mRNA vaccines, we are expanding the reach of mRNA across the globe.
Moderna is committed to working on multiple levels to optimize the impact of mRNA vaccines and therapeutics. We are building a state-of-the-art mRNA facility in Africa, in part to ensure future access in Africa to mRNA vaccines in future pandemics.
Addressing ultra-rare diseases
We are providing an investigational mRNA Crigler-Najjar Syndrome Type 1 therapy (mRNA-3351) to the Institute for Life Changing Medicines (ILCM) free of charge. CN-1 is an ultra-rare disease.
We recently launched mRNA Access, a program that aims to accelerate the creation of new vaccines using mRNA technology in collaboration with global partners. Researchers beyond Moderna can take advantage of the flexibility afforded by our platform to develop novel mRNA medicines for emerging and neglected infectious diseases.
Moderna employees drive our achievements in bringing innovative medicines to patients. Our commitment to them is rooted in an inclusive environment that fosters well-being. We believe that we will only succeed in our goals if we are able to attract and retain individuals of diverse backgrounds and of all ages, genders, ethnicities, religions, home countries and sexual orientations. Benefits like professional development programs, 401(k) matching, stock options and generous paid leave mean our team is empowered to achieve great things.
women in 2021
racially/ethnically diverse in 2021
women in Moderna leadership (VP & above in 2021)
CEO Action for Diversity and Inclusion Pledge
The CEO pledge outlines a specific set of actions the signatory CEOs will take to cultivate a trusting environment where all ideas are welcome and employees feel comfortable and empowered to have discussions about diversity and inclusion.
We have pledged to achieve net-zero carbon emissions by 2030. Other initiatives include fully subsidized green transportation across our campuses in the US, and including sustainable design elements in our new projects.
carbon emissions by 2030
subsidized green transportation across our campuses in the US
From active involvement in local schools to raising awareness for rare diseases, we are involved in our local and global community.
Bringing awareness to a common yet potentially dangerous virus for pregnant women, infants and those with weakened immune systems.
Family day at Moderna
More than 130 colleagues and their family members visited our Moderna Technology Center for the site’s first Family Day event.
Volunteering in our local community
Moderna colleagues and family members help prepare meals at the Pine Street Inn.
Supporting young scientists
Hosting middle school students from Breakthrough Greater Boston for a day of science experiments and judging the annual Massachusetts Science Fair.
Moderna Charitable Foundation
We launched the Moderna Charitable Foundation in 2022 to support organizations and causes that promote public health and access to quality healthcare, advancing scientific education and innovation, and advocating for diversity and inclusion, particularly in underserved populations.
Board of Directors
Our Board of Directors sets high standards for our employees, officers and directors. They believe that sound governance practices and policies are important to our success as a company and to obtaining the trust of our stakeholders. The Moderna Nominating and Governance Committee provides for oversight of ESG matters.
Our internal oversight committees
Scientific Advisory Board
Corporate Compliance Committee
Enterprise Risk Committee